PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Pancreatin - Pancreatic insufficiency

PAD Profile : Pancreatin - Pancreatic insufficiency Important

Keywords :
Pancreatic enzyme deficiency, Pancreatic enzyme replacement therapy, PERT, pancreatin supplements
Brand Names Include :
Creon, Creon Micro, Pancrex V, Pancrex V Forte, Nutrizym 22,
Important Information :
Prescribe by brand - product with multiple ingredients. GP initiation following specialist recommendation.

Traffic Light Status

Status 1 of 2.

Status :
Blue
Important
Formulations :
  • Capsules
  • Tablets
Important Information :
Nutrizym recommended in pregnancy / breastfeeding due to theoretical concern of phthalate content of Creon.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Blue
Important
Formulations :
  • Powder
Important Information :
SASH restrict to tube-fed patients only (Pancrex V powder)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

No indications returned.

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
03 April 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee noted the ongoing shortages of pancreatic enzyme replacement therapies.

Updated information can be found on the Pancreatic Society of Great Britain & Ireland webite: Position Statement: Pert Shortage | Pancreatic Society of Great Britain and Ireland (psgbi.org)

Associated BNF Codes

01. Gastro-Intestinal System
01.09.04. Pancreatin
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More